The controversial nature of IL-17 production in relation to T1D is likely due to the fact that IL-17 is in actuality produced by a spectrum of T cell phenotypes possessing both varied and distinct effector functions. The gene discussed is IL17A; the disease is type 1 diabetes mellitus.